| Symbol | DRIO |
|---|---|
| Name | DARIOHEALTH CORP. |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | Medical/Dental Instruments |
| Address | 8 HATOKHEN STREET,CAESAREA NORTH INDUSTRIAL PARK, CAESAREA, 3088900, Israel |
| Telephone | +972 47704055 |
| Fax | — |
| — | |
| Website | https://www.mydario.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001533998 |
| Description | DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Darios next-generation, AI-powered, digital therapeutic platform supports more than just an individuals disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Additional info from NASDAQ: |
Dario Expands Provider-Backed Cardiometabolic Platform with New Womens Health and Sleep Solutions Aligning with Client Demand
Read moreDarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
Read moreDario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
Read moreDirector Matheis Dennis 🟡 adjusted position in 14.4K shares (1 derivative) of DarioHealth Corp. (DRIO) at $1,000.00 ($1.1M) Transaction Date: Aug 12, 2024 | Filing ID: 087626
Read moreNew Form 424B5 - DarioHealth Corp. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001104659-26-085887 <b>Size:</b> 370 KB
Read moreDario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Read moreFortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
Read moreDario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
Read moreDario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
Read more